Prevalence of Fosfomycin Resistance among CTX-M-Producing Escherichia coli Clinical Isolates in Japan and Identification of Novel Plasmid-Mediated Fosfomycin-Modifying Enzymes

被引：133

作者：

Wachino, Jun-ichi ^{[1
]}

Yamane, Kunikazu ^{[1
]}

Suzuki, Satowa ^{[1
]}

Kimura, Kouji ^{[1
]}

Arakawa, Yoshichika ^{[1
]}

机构：

[1] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo 2080011, Japan

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2010年 / 54卷 / 07期

关键词：

MULTIDRUG-RESISTANT; PROTEIN FOSA; INFECTIONS; SITE;

D O I：

10.1128/AAC.01834-09

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We evaluated the in vitro activity of fosfomycin against a total of 192 CTX-M beta-lactamase-producing Escherichia coli strains isolated in 70 Japanese clinical settings. Most of the isolates (96.4%) were found to be susceptible to fosfomycin. On the other hand, some of the resistant isolates were confirmed to harbor the novel transferable fosfomycin resistance determinants named FosA3 and FosC2, which efficaciously inactivate fosfomycin through glutathione S-transferase activity.

引用

页码：3061 / 3064

页数：4

共 13 条

[1] Functional analysis of active site residues of the fosfomycin resistance enzyme FosA from Pseudomonas aeruginosa
Beharry, Z
Palzkill, T
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (18) : 17786 - 17791
[2] Elucidation of a monovalent cation dependence and characterization of the divalent cation binding site of the fosfomycin resistance protein (FosA)
Bernat, BA
Laughlin, LT
Armstrong, RN
[J]. BIOCHEMISTRY, 1999, 38 (23) : 7462 - 7469
[3] Fosfomycin resistance protein (FosA) is a manganese metalloglutathione transferase related to glyoxalase I and the extradiol dioxygenases
Bernat, BA
Laughlin, LT
Armstrong, RN
[J]. BIOCHEMISTRY, 1997, 36 (11) : 3050 - 3055
[4] In Vitro Activity of Fosfomycin against blaKPC-Containing Klebsiella pneumoniae Isolates, Including Those Nonsusceptible to Tigecycline and/or Colistin
Endimiani, Andrea
Patel, Gopi
Hujer, Kristine M.
Swaminathan, Mahesh
Perez, Federico
Rice, Louis B.
Jacobs, Michael R.
Bonomo, Robert A.
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (01) : 526 - 529
[5] Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
Falagas, Matthew E.
Kastoris, Antonia C.
Kapaskelis, Anastasios M.
Karageorgopoulos, Drosos E.
[J]. LANCET INFECTIOUS DISEASES, 2010, 10 (01) : 43 - 50
[6] Complete Genome Sequence of the N2-Fixing Broad Host Range Endophyte Klebsiella pneumoniae 342 and Virulence Predictions Verified in Mice
Fouts, Derrick E.
Tyler, Heather L.
DeBoy, Robert T.
Daugherty, Sean
Ren, Qinghu
Badger, Jonathan H.
Durkin, Anthony S.
Huot, Heather
Shrivastava, Susmita
Kothari, Sagar
Dodson, Robert J.
Mohamoud, Yasmin
Khouri, Hoda
Roesch, Luiz F. W.
Krogfelt, Karen A.
Struve, Carsten
Triplett, Eric W.
Methe, Barbara A.
[J]. PLOS GENETICS, 2008, 4 (07):
[7] Multidrug-Resistant Gram-Negative Infections What are the Treatment Options?
Giamarellou, Helen
Poulakou, Garyphallia
[J]. DRUGS, 2009, 69 (14) : 1879 - 1901
[8] PLASMID-DETERMINED RESISTANCE TO FOSFOMYCIN IN SERRATIA-MARCESCENS
MENDOZA, C
GARCIA, JM
LLANEZA, J
MENDEZ, FJ
HARDISSON, C
ORTIZ, JM
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (02) : 215 - 219
[9] Biological costs and mechanisms of fosfomycin resistance in Escherichia coli
Nilsson, AI
Berg, OG
Aspevall, O
Kahlmeter, G
Andersson, DI
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (09) : 2850 - 2858
[10] Crystal structure of a genomically encoded fosfomycin resistance protein (FosA) at 1.19 Å resolution by MAD phasing off the L-III edge of Tl
Rife, CL
Pharris, RE
Newcomer, ME
Armstrong, RN
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (37) : 11001 - 11003

← 1 2 →